Table 1.
Expression level of ACTG1 protein in PDAC patients
| Variables | Cases | ACTG1 level | P | |
|---|---|---|---|---|
|
|
|
|
|
|
| (n=149) | Low (n=75) | High (n=74) | ||
| Age (years) | ||||
| ≤60 | 62 | 32 | 30 | 0.792 |
| >60 | 87 | 43 | 44 | |
| Sex | ||||
| Female | 51 | 25 | 26 | 0.817 |
| Male | 98 | 50 | 48 | |
| Location | ||||
| Head | 92 | 42 | 50 | 0.146 |
| Body or tail | 57 | 33 | 24 | |
| Pathological grade | ||||
| Grade 1-2 | 95 | 53 | 42 | 0.077 |
| Grade 3 | 54 | 22 | 32 | |
| T stage | ||||
| T1 | 38 | 26 | 12 | 0.032* |
| T2 | 66 | 28 | 38 | |
| T3 | 45 | 21 | 24 | |
| Vessel invasion | ||||
| Negative | 99 | 50 | 49 | 0.954 |
| Positive | 50 | 25 | 25 | |
| Lymph node metastasis | ||||
| Negative | 87 | 40 | 47 | 0.207 |
| Positive | 62 | 35 | 27 | |
Note: * Statistically significant by Chi-square test.